Acta Neurochirurgica

, Volume 157, Issue 11, pp 1887–1895 | Cite as

Temporal lobe epilepsy and cavernous malformations: surgical strategies and long-term outcomes

  • Fernando L. Vale
  • Andrew C. Vivas
  • Jotham Manwaring
  • Mike R. Schoenberg
  • Selim R. Benbadis
Clinical Article - Functional

Abstract

Objective

Cerebral cavernous malformations (CCM) of the temporal lobe often present with seizures. Surgical resection of these lesions can offer durable seizure control. There is, however, no universally accepted methodology for assessing and surgically treating these patients. We propose an algorithm to maximize positive surgical outcomes (seizure control) while minimizing post-surgical neurological deficit.

Methods

A retrospective review of 34 patients who underwent epilepsy surgery for radiographically proven temporal lobe CCM was conducted. Patients underwent a relatively standard work-up for seizure localization. In patients with mesial temporal lobe epilepsy (MTLE), a complete resection of the epileptogenic zone was performed including amygdalo-hippocampectomy in addition to a lesionectomy if not contraindicated by pre-operative work-up. Patients with neocortical epilepsy underwent intraoperative electrocorticography (ECoG)-guided lesionectomy.

Results

Seizure-free rate for mesial and neocortical (anterior, lateral, and basal) location was 90 vs. 83 %, respectively. Complete resection of the lesion, irrespective of location, was statistically significant for seizure control (p = 0.018). There was no difference in seizure control based on disease duration or location (p > 0.05). Patients with mesial temporal CCM who presented with MTLE were presumed to also have mesial temporal sclerosis (MTS), or dual pathology. These patients underwent routine resection of the mesial structures. Interestingly, patients who had MTLE and basal (neocortical) lesions who underwent a mesial resection for suspected MTS were found not to have dual pathology.

Conclusions

Patients with temporal lobe CCM should be offered resection for durable seizure control, prevention of secondary epileptogenic foci, and elimination of hemorrhage risk. The preoperative work-up should follow a team approach. Surgical intervention should include complete lesionectomy in all cases. Intra or extra-operative ECoG for neocortical lesions may be beneficial. Management of mesial temporal CCMs (archicortex) should consider resection of a well-defined epileptogenic zone (including mesial structures) due to high probability of pathologically proven MTS. The use of this treatment algorithm is useful for the education and treatment of these patients.

Keywords

Epilepsy Cavernous malformation Temporal lobe Pathology 

Abbreviations

MTLE

Mesial temporal lobe epilepsy

MTS

Mesial temporal sclerosis

ECoG

Electrocorticography

MRI

Magnetic resonance imaging

CCM

Cerebral cavernous malformations

EC

Engel classification

EEG

Electroencephalography

Notes

Acknowledgments

The authors thank Jason Liounakos, B.S., for his help with data collection, Katie Eichsteadt, MA, for the statistical analysis, and Mark Greenberg, M.D., for his art work.

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Financial support

None.

References

  1. 1.
    Awad I, Jabbour P (2006) Cerebral cavernous malformations and epilepsy. Neurosurg Focus 21(1):E7CrossRefPubMedGoogle Scholar
  2. 2.
    Awad IA, Rosenfeld J, Ahl J, Hahn JF, Lüders H (1991) Intractable epilepsy and structural lesions of the brain: mapping, resection strategies, and seizure outcome. Epilepsia 32(2):179–186CrossRefPubMedGoogle Scholar
  3. 3.
    Baumann CR, Acciarri N, Bertalanffy H, Devinsky O, Elger CE, Lo Russo G, Cossu M, Sure U, Singh A, Stefan H, Hammen T, Georgiadis D, Baumgartner RW, Andermann F, Siegel AM (2007) Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia 48(3):559–563CrossRefPubMedGoogle Scholar
  4. 4.
    Baumann CR, Schuknecht B, Lo Russo G, Cossu M, Citterio A, Andermann F, Siegel AM (2006) Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia 47(3):563–566CrossRefPubMedGoogle Scholar
  5. 5.
    Blumer D, Wakhlu S, Davies K, Hermann B (1998) Psychiatric outcome of temporal lobectomy for epilepsy: incidence and treatment of psychiatric complications. Epilepsia 39(5):478–486CrossRefPubMedGoogle Scholar
  6. 6.
    Cankurtaran ES, Ulug B, Saygi S, Tiryaki A, Akalan N (2005) Psychiatric morbidity, quality of life, and disability in mesial temporal lobe epilepsy patients before and after anterior temporal lobectomy. Epilepsy Behav 7(1):116–122CrossRefPubMedGoogle Scholar
  7. 7.
    Cappabianca P, Alfieri A, Maiuri F, Mariniello G, Cirillo S, de Divitiis E (1997) Supratentorial cavernous malformations and epilepsy: seizure outcome after lesionectomy on a series of 35 patients. Clin Neurol Neurosurg 99(3):179–183CrossRefPubMedGoogle Scholar
  8. 8.
    Chang EF, Gabriel RA, Potts MB, Garcia PA, Barbaro NM, Lawton MT (2009) Seizure characteristics and control after microsurgical resection of supratentorial cerebral cavernous malformations. Neurosurgery 65(1):31–37, discussion 37-8 CrossRefPubMedGoogle Scholar
  9. 9.
    Cohen DS, Zubay GP, Goodman RR (1995) Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg 83(2):237–242CrossRefPubMedGoogle Scholar
  10. 10.
    Dalyai RT, Ghobrial G, Awad I, Tjoumakaris S, Gonzalez LF, Dumont AS, Chalouhi N, Randazzo C, Rosenwasser R, Jabbour P (2011) Management of incidental cavernous malformation: a review. Neurosurg Focus 31(6):E5CrossRefPubMedGoogle Scholar
  11. 11.
    D’Angelo VA, De Bonis C, Amoroso R, Cali A, D’Agruma L, Guarnieri V, Muscarella LA, Zelante L, Bisceglia M, Scarabino T, Catapano D (2006) Supratentorial cerebral cavernous malformations: clinical, surgical, and genetic involvement. Neurosurg Focus 21(1):E9PubMedGoogle Scholar
  12. 12.
    Duckworth EA, Vale FL (2008) Trephine epilepsy surgery: the inferior temporal gyrus approach. Neurosurgery 63(1):ONS156–ONS160CrossRefPubMedGoogle Scholar
  13. 13.
    Engel J Jr, Van Ness PC, Rasmussen TB, Ojemann LM (1993) Surgical treatment of the epilepsies outcome with respect to epileptic seizures. In: Engel J Jr (ed) Surgical treatment of the epilepsies, 2nd edn. Raven Press, New York, pp 609–621Google Scholar
  14. 14.
    Englot DJ, Berger MS, Barbaro NM, Chang EF (2011) Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg 115(2):240–244CrossRefPubMedGoogle Scholar
  15. 15.
    Englot DJ, Han SJ, Berger MS, Barbaro NM, Chang EF (2012) Extent of surgical resection predicts seizure freedom in low-grade temporal lobe brain tumors. Neurosurgery 70:921–928CrossRefPubMedGoogle Scholar
  16. 16.
    Falconer MA, Kennedy WA (1961) Epilepsy due to small focal temporal lesions with bilateral independent spike-discharging foci. A study of seven cases relieved by operation. J Neurol Neurosurg Psychiatry 24:205–212PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Ferroli P, Casazza M, Marras C, Mendola C, Franzini A, Broggi G (2006) Cerebral cavernomas and seizures: a retrospective study on 163 patients who underwent pure lesionectomy. Neurol Sci 26(6):390–394CrossRefPubMedGoogle Scholar
  18. 18.
    Gilioli I, Vignoli A, Visani E, Casazza M, Canafoglia L, Chiesa V, Gardella E, La Briola F, Panzica F, Avanzini G, Canevini MP, Franceschetti S, Binelli S (2012) Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of “new” antiepileptic drugs. Epilepsia 53(4):733–740CrossRefPubMedGoogle Scholar
  19. 19.
    Gilliam F, Kuzniecky R, Meador K, Martin R, Sawrie S, Viikinsalo M, Morawetz R, Faught E (1999) Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology 53(4):687–694CrossRefPubMedGoogle Scholar
  20. 20.
    Ghareeb F, Duffau H (2012) Intractable epilepsy in paralimbic Word Health Organization Grade II gliomas: should the hippocampus be resected when not invaded by the tumor? J Neurosurg 116(6):1226–1234CrossRefPubMedGoogle Scholar
  21. 21.
    Gloor P (1977) The temporal lobe and limbic system. Oxford University Press, New York, pp 3–19Google Scholar
  22. 22.
    Glosser G, Zwil AS, Glosser DS, O’Connor MJ, Sperling MR (2000) Psychiatric aspects of temporal lobe epilepsy before and after anterior temporal lobectomy. J Neurol Neurosurg Psychiatry 68(1):53–58PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Hammen T, Romstöck J, Dörfler A, Kerling F, Buchfelder M, Stefan H (2007) Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure 16(3):248–253CrossRefPubMedGoogle Scholar
  24. 24.
    Hess R (1970) Seizures in brain tumors. Electroencephalogr Clin Neurophysiol 28(2):217PubMedGoogle Scholar
  25. 25.
    Kivelev J, Niemelä M, Blomstedt G, Roivainen R, Lehecka M, Hernesniemi J (2011) Microsurgical treatment of temporal lobe cavernomas. Acta Neurochir (Wien) 153(2):261–270CrossRefGoogle Scholar
  26. 26.
    Kim J, Kim CH, Chung CK (2014) Longitudinal changes in seizure outcomes after resection of cerebral cavernous malformations in patients presenting with seizures: a long-term follow-up of 46 patients. Acta Neurochir 156:1539–1547CrossRefPubMedGoogle Scholar
  27. 27.
    Kondziolka D, Lunsford LD, Kestle JR (1995) The natural history of cerebral cavernous malformations. J Neurosurg 83(5):820–824CrossRefPubMedGoogle Scholar
  28. 28.
    Markand ON, Salanova V, Whelihan E, Emsley CL (2000) Health-related quality of life outcome in medically refractory epilepsy treated with anterior temporal lobectomy. Epilepsia 41(6):749–759CrossRefPubMedGoogle Scholar
  29. 29.
    Menzler K, Chen X, Thiel P, Iwinska-Zelder J, Miller D, Reuss A, Hamer HM, Reis J, Pagenstecher A, Knake S, Bertalanffy H, Rosenow F, Sure U (2010) Epileptogenicity of cavernomas depends on (archi-) cortical localization. Neurosurgery 67(4):918–924CrossRefPubMedGoogle Scholar
  30. 30.
    Moran NF, Fish DR, Kitchen N, Shorvon S, Kendall BE, Stevens JM (1999) Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series. J Neurol Neurosurg Psychiatry 66(5):561–568PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Morrell F (1960) Secondary epileptogenic lesions. Epilepsia 1:538–560CrossRefPubMedGoogle Scholar
  32. 32.
    Noto S, Fujii M, Akimura T, Imoto H, Nomura S, Kajiwara K, Kato S, Fujisawa H, Suzuki M (2005) Management of patients with cavernous angiomas presenting epileptic seizures. Surg Neurol 64(6):495–498, discussion 498-9 CrossRefPubMedGoogle Scholar
  33. 33.
    Robinson JR, Awad IA, Little JR (1991) Natural history of the cavernous angioma. J Neurosurg 75(5):709–714CrossRefPubMedGoogle Scholar
  34. 34.
    Rocamora R, Mader I, Zentner J, Schulze-Bonhage A (2009) Epilepsy surgery in patients with multiple cerebral cavernous malformations. Seizure 18(4):241–245CrossRefPubMedGoogle Scholar
  35. 35.
    Rydenhag B, Flink R, Malmgren K (2013) Surgical outcomes in patients with epileptogenic tumours and cavernomas in Sweden: good seizure control but late referrals. J Neurol Neurosurg Psychiatry 84(1):49–53CrossRefPubMedGoogle Scholar
  36. 36.
    Schramm J (2008) Temporal lobe epilepsy surgery and the quest for optimal extent of resection: a review. Epilepsia 49(8):1296–1307PubMedGoogle Scholar
  37. 37.
    Selai CE, Elstner K, Trimble MR (2000) Quality of life pre and post epilepsy surgery. Epilepsy Res 38(1):67–74CrossRefPubMedGoogle Scholar
  38. 38.
    Stavrou I, Baumgartner C, Frischer JM, Trattnig S, Knosp E (2008) Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients. Neurosurgery 63:888–896, discussion 897 CrossRefPubMedGoogle Scholar
  39. 39.
    Upchurch K, Stern JM, Salamon N, Dewar S, Engel J Jr, Vinters HV, Fried I (2010) Epileptogenic temporal cavernous malformations: operative strategies and postoperative seizure outcomes. Seizure 19:120–128CrossRefPubMedGoogle Scholar
  40. 40.
    Uribe JS, Vale FL (2009) Limited access inferior temporal gyrus approach for mesial basal temporal lobe tumors. J Neurosurg 110(1):137–146CrossRefPubMedGoogle Scholar
  41. 41.
    Van Gompel JJ, Rubio J, Cascino GD, Worrell GA, Meyer FB (2009) Electrocorticography-guided resection of temporal cavernoma: is electrocorticography warranted and does it alter the surgical approach? J Neurosurg 110(6):1179–1185PubMedCentralCrossRefPubMedGoogle Scholar
  42. 42.
    von der Brelie C, Schramm J (2011) Cerebral cavernous malformations and intractable epilepsy: the limited usefulness of current literature. Acta Neurochir (Wien) 153(2):249–259CrossRefGoogle Scholar
  43. 43.
    Wiebe S, Blume WT, Girvin JP, Eliasziw M (2001) Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 345(5):311–318CrossRefPubMedGoogle Scholar
  44. 44.
    Wolf HK, Wiestler OD (1993) Surgical pathology of chronic epileptic seizure disorders. Brain Pathol 3(4):371–380CrossRefPubMedGoogle Scholar
  45. 45.
    Yeon JY, Kim JS, Choi SJ, Seo DW, Hong SB, Hong SC (2009) Supratentorial cavernous angiomas presenting with seizures: surgical outcomes in 60 consecutives patients. Seizure 18:14–20CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2015

Authors and Affiliations

  • Fernando L. Vale
    • 1
  • Andrew C. Vivas
    • 1
  • Jotham Manwaring
    • 1
  • Mike R. Schoenberg
    • 2
  • Selim R. Benbadis
    • 3
  1. 1.Department of Neurosurgery & Brain RepairMorsani College of Medicine, University of South FloridaTampaUSA
  2. 2.Department of Psychiatry and Behavioral NeurosciencesUniversity of South Florida Morsani College of MedicineTampaUSA
  3. 3.Department of NeurologyMorsani College of Medicine, University of South FloridaTampaUSA

Personalised recommendations